Hims & Hers Health (HIMS) Announces Access to GLP-1 Injections

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. LEVI
2. SBUX
3. NVDA
4. SPCX
5. SPY
6. GOOGL
7. APLD
8. USO
9. STZ
10. AAPL

Go back to Hims & Hers Health (HIMS) Announces Access to GLP-1 Injections

Hims and Hers (HIMS) PT Raised to $24 at Canaccord Genuity

May 22, 2024 5:29 AM EDT

Canaccord Genuity analyst Maria Ripps raised the price target on Hims and Hers (NYSE: HIMS) to $24.00 (from $20.00) while maintaining a Buy rating.

The analyst comments "On Monday, 5/20, Hims & Hers announced the addition of GLP-1 treatment to its portfolio of weight loss solutions, with prices... More

Citi Reiterates Buy Rating on Hims and Hers (HIMS)

May 20, 2024 11:49 AM EDT

Citi analyst Daniel Grosslight reiterated a Buy rating and $16.00 price target on Hims and Hers (NYSE: HIMS)

The analyst comments "As widely anticipated, HIMS launched its GLP-1 offering this morning, which we think will significantly increase the interest in its weight loss offering.... More